▲ S&P 500 +—%|▲ Stock Advisor +—%Join The Motley Fool
Pfizer
Healthcare stock Pfizer tops this list, simply because I think it’s overdue for a rally. It has tremendous value and also offers a mouthwatering dividend that yields 6.3%, which the company is able to support thanks to strong free cash flow.
The market has been discounting the stock due to the long-term uncertainty around its future growth. Pfizer’s guidance for the year calls for revenue to be within a range of $60.5 billion and $62.5 billion, which implies a slight decline from a year ago when its top line totaled $62.6 billion. There are also concerns about some of its key drugs losing patent protection in the near future, which is a common issue for healthcare companies at one point or another.
Expand

NYSE: PFE
Pfizer
Premium Feature
Moneyball Superscore
65/100
Today’s Change
(-0.35%) $-0.10
Current Price
$27.32
Key Data Points
Market Cap
$156BMarket cap calculated using publicly traded s outstanding only. Does not include unlisted, private, or dual-class non-traded s. Implied market cap may vary.
Day’s Range
$27.20 – $27.71
52wk Range
$23.62 – $29.21
Volume
10.9M
Avg Vol
36.7M
Gross Margin
64.83%
Dividend Yield
6.28%
However, I think the market has overreacted to the risk. Pfizer has been investing in growing its pipeline. The roof hasn’t caved in on the healthcare stock, but many investors appear overly hesitant nonetheless, with the stock down 35% in the past five years. It’s trading at just 10 times its expected future earnings, making it a dirt cheap stock to buy that also offers a great yield.
ExxonMobil
UnPfizer, s of ExxonMobil have been soaring this year. They’re up around 37% due to rising oil prices. I Exxon’s stock as a hedge against inflation and market uncertainty. Oil prices may remain elevated for the foreseeable future, as I’m skeptical of the war in Iran ending anytime soon.
At 2.5%, Exxon’s yield isn’t astronomical, but it’s still more than twice the rate of the S&P 500 average of 1.1%. This is also a top dividend growth stock to own, with Exxon raising its payout for decades, giving investors a ton of incentive to just buy and hold for the long haul.
Expand

NYSE: XOM
ExxonMobil
Premium Feature
Moneyball Superscore
70/100
Today’s Change
(1.13%) $1.85
Current Price
$165.85
Key Data Points
Market Cap
$674BMarket cap calculated using publicly traded s outstanding only. Does not include unlisted, private, or dual-class non-traded s. Implied market cap may vary.
Day’s Range
$162.94 – $165.94
52wk Range
$110.39 – $176.41
Volume
3.6M
Avg Vol
14.2M
Gross Margin
20.88%
Dividend Yield
2.51%
Exxon, despite its sharp rally this year, still trades at a fairly modest forward price-to-earnings (P/E) multiple of 15, suggesting that analysts continue to see much more profit growth ahead. This can be a terrific stock to buy right now, for not only the dividend income, but also the safety and stability it can offer if there’s a downturn in the markets.
Realty Income
Another struggling dividend stock to make this list is Realty Income. It’s declined 4% this year, and over a five-year stretch, it’s down around 18%. While it hasn’t been on a steep sell-off, investors can definitely buy it at a reduced price these days.
At 6.1%, its yield is almost as high as Pfizer’s. It also has a dividend growth streak that spans decades, not unExxon. But what sets it apart from other dividend stocks is that it makes payments on a monthly basis. The more frequent payouts make it an ideal option for investors who want to collect recurring income, as they won’t have to wait long to get it, with payments flowing in every month.
Expand

NYSE: O
Realty Income
Premium Feature
Moneyball Superscore
84/100
Today’s Change
(0.54%) $0.29
Current Price
$54.06
Key Data Points
Market Cap
$51BMarket cap calculated using publicly traded s outstanding only. Does not include unlisted, private, or dual-class non-traded s. Implied market cap may vary.
Day’s Range
$53.88 – $54.33
52wk Range
$53.33 – $67.94
Volume
2.2M
Avg Vol
6.4M
Gross Margin
50.82%
Dividend Yield
6.03%
Realty Income is a top real estate investment trust that has a broad mix of tenants, making its business fairly stable overall. Its forward P/E of 34 is a bit rich compared to the other stocks on this list, but investors have been willing to pay even higher premiums in the past for the stock, due to its stability and the attractiveness of its monthly payout.
Read Next

Why Pfizer Might Be the Most Underrated Dividend Stock to Buy Right Now

•By Sara Appino
Eli Lilly vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?

Better High-Yield Dividend Stock: Pfizer or Novo Nordisk?

•By James Brumley
Here’s Exactly Why I’m Not Afraid of Pfizer’s 6% Dividend Yield

•By Justin Pope
3 Dirt Cheap Dividend Stocks Worth Buying in October

•By Keith Speights
My 3 Favorite Ultra-High-Yield Dividend Stocks to Buy for October
About the Author
David Jagielski, CPA, has been a contributing Motley Fool stock market analyst covering healthcare, consumer staples, consumer discretionary, and technology stocks since 2017. David has more than 10 years of experience in finance roles across businesses of different sizes and sectors. He holds a Certified Public Accountant designation in Canada.
Stocks Mentioned

Pfizer
NYSE: PFE
$27.32
(-0.35%)-$0.10
![]()
Motley Fool Stock Advisor’s Latest Pick
—% Avg Return

ExxonMobil
NYSE: XOM
$165.92
(+1.17%)+$1.92

Realty Income
NYSE: O
$54.06
(+0.54%)+$0.29
*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool’s premium services.
Sumber Artikel:
Fool.com
